Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Chief Legal Officer sold 9,492 shares at $21.96 ($208,421)
  8. 4 Open-market sale Chief Medical Officer sold 51,914 shares at an average $22.01 ($1,142,375)
  9. 4 Open-market sale Chief Legal Officer sold 45,119 shares at an average $22.10 ($996,963)
  10. 4 Open-market sale Chief Scientific Officer sold 21,790 shares at an average $21.64 ($471,437)
  11. 4 Open-market sale Chief Financial Officer sold 15,037 shares at an average $21.64 ($325,383)
  12. 4 Open-market sale President and CEO sold 33,260 shares at an average $21.64 ($719,735)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale Chief Legal Officer sold 20,416 shares at an average $23.45 ($478,845)
  15. 4 Open-market sale Chief Legal Officer sold 45,000 shares at an average $24.08 ($1,083,718)
  16. 4 Open-market sale Chief Financial Officer sold 87,339 shares at an average $26.45 ($2,310,106)
  17. 4 Open-market sale President and CEO sold 30,000 shares at $26.84 ($805,239)
  18. 4 Shares withheld for taxes Chief Medical Officer gave up 7,940 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Legal Officer gave up 6,840 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Financial Officer gave up 10,177 shares (to pay taxes)

Page 10 of 21 · 414 filings